Navigation Links
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
Date:6/12/2008

rious infections. Two patients

reported tuberculosis, one after three months and another after 13

months of exposure.

About Rheumatoid Arthritis

Unlike osteoarthritis, the most common form of arthritis, RA is an autoimmune disease where joints are inflamed, which may lead to damage of the joints' interior and the surrounding bone. The joints most commonly affected during the beginning of the disease are the smaller joints of the fingers, feet and wrists. The elbows, knees, ankles and hips can be affected, but less often. Although there is no cure for RA, people continue to seek treatments that not only alleviate the pain and inflammation but also slow disease progression, thereby inhibiting the joint damage that can hinder patients from performing daily activities. Five million people worldwide are currently living with RA and most of them are between the ages of 25 and 55.

Important Safety Information

Globally, prescribing information varies; refer to the individual country product label for complete information.

Serious infections, sepsis, rare cases of tuberculosis (TB), and opportunistic infections, including fatalities, have been reported with the use of TNF antagonists, including HUMIRA. Many of the serious infections have occurred in patients on concomitant immunosuppressive therapy that, in addition to their underlying disease could predispose them to infections. Patients must be monitored closely for infections, including tuberculosis, before, during and after treatment with HUMIRA. Treatment should not be initiated in patients with active infections until infections are controlled. HUMIRA should not be used by patients with active TB or other severe infections such as sepsis and opportunistic infections. Patients who develop new infections while using HUMIRA should be monitored closely. HUMIRA should be discontinued if a patient develops a new serious infection until infections are controlled. Phy
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Smoking may strongly increase long-term risk of eye disease
2. Long-Term Fatigue Plagues Cancer Survivors
3. Dont Ignore Tough or Long-Term Stomach Pain
4. Shaking may cause brain damage and serious long-term effects to infants
5. Sexual function affected by stem cell transplant according to long-term study
6. Smoking can harm the long-term effects of some oral surgery procedures
7. Childhood Obesity Epidemic a Long-Term Challenge
8. Conseco to Host Follow-Up Long-Term Care Conference Call
9. New Report Finds Information Technology Essential But Not Sufficient in Long-Term Care
10. No Link Between Amateur Boxing, Long-Term Brain Damage
11. No strong evidence linking amateur boxing with long-term brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... November 27, 2014 In a ... allot to sleep has lessened, and due to ... the quality of sleep has eroded. According to ... on the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This ... index by an incalculable amount, leading not only ...
(Date:11/27/2014)... York (PRWEB) November 27, 2014 ... have been filed in a consolidated litigation now ... reports. , Documents recently updated in the ... included in the state proceeding, all of which ... disorder and other psychiatric conditions. Many of the ...
(Date:11/27/2014)... THURSDAY, Nov. 27, 2014 (HealthDay News) -- Thanksgiving meals ... eat a gluten-free diet, an expert says. Many ... potatoes and cranberry sauce -- are gluten-free, but "when ... may need to be considered," Dr. Anca Safta, director ... Wake Forest Baptist Medical Center in North Carolina, said ...
(Date:11/27/2014)... Now that Thanksgiving is finally here and ... Emassagechair.com has announced its eagerly awaited, once yearly ... Negotiating on behalf of their customers, and drawing on ... has generated significant buzz in the industry with the ... , Shoppers are excited for significant savings available on ...
(Date:11/27/2014)... DC (PRWEB) November 27, 2014 “Wekho” was ... features the latest and coolest mobile applications on the iOS, ... and host of NewsWatch, conducted the app review ... locations instead of people. , An interesting new way to ... iOS and Android devices. It’s called Wekho and it’s ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2
... ... of rural Hispanic families found that untreated tooth decay in mothers almost doubled the odds ... of mothers and their children, the authors say. , ... (Vocus) June 15, 2010 -- A UCSF study examining the oral ...
... a greater likelihood of poorer outcomes, many patients newly-diagnosed ... research indicates that among the factors associated with this ... patient-physician communication and older age, with black patients more ... in the June 16 issue of JAMA . ...
... patients and can reduce costs, study finds , TUESDAY, June ... as well as high doses of injected steroids for patients ... , Yet, some 90 percent of these COPD patients are ... guidelines, claims the study appearing in the June 16 ...
... The ... Tao Text for the 21st Century and Presents the Essence and Secrets of Ancient Teachings ... and More, , ... 2010 -- In the newly released sixth book of his best-selling Soul Power Series, Tao I: ...
... ... specializing in Emergency Department and Hospitalist Medicine Management companies, partners with Lock Haven ... Pennsylvania., , ... Ft. Lauderdale, Florida (Vocus) June 15, 2010 -- Hospital Physician Partners ...
... pandemic influenza vaccine and then exposed to high levels of ... get sick or die, report scientists funded by the National ... National Institutes of Health. The new vaccine works against the ... H1N1 influenza share features that allow vaccine-generated antibodies to recognize ...
Cached Medicine News:Health News:If Mother Has Tooth Decay, Odds Increase That Child Does Too 2Health News:If Mother Has Tooth Decay, Odds Increase That Child Does Too 3Health News:Study examines reasons patients with early stage lung cancer do not have surgery 2Health News:Study examines reasons patients with early stage lung cancer do not have surgery 3Health News:IV Steroids May Be Overkill in COPD Patients 2Health News:IV Steroids May Be Overkill in COPD Patients 3Health News:TAO l: The Way of All Life, by Zhi Gang Sha Reaches #6 on New York Times Bestseller List 2Health News:TAO l: The Way of All Life, by Zhi Gang Sha Reaches #6 on New York Times Bestseller List 3Health News:Hospital Physician Partners and Lock Haven Hospital Announce New Emergency Department Partnership 2Health News:Hospital Physician Partners and Lock Haven Hospital Announce New Emergency Department Partnership 3Health News:NIH-funded scientists find 2009 H1N1 pandemic influenza vaccine protects mice from 1918 flu virus 2
(Date:11/26/2014)... Investor-Edge has initiated coverage on the ... Pharma PLC (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... JNJ ), and Theravance Inc. (NASDAQ: THRX ). ... http://investor-edge.com/register . On Tuesday, November 25, 2014, ... Jones Industrial Average edged 0.02% lower, to finish the day ...
(Date:11/26/2014)... SHANGHAI , Nov. 26, 2014  CARsgen, a ... (CAR-T) cell immunotherapy to treat a variety of cancers, ... led by BVCF, a China -based ... an immunotherapy company focused on the development of new ... collaboration with Shanghai Cancer Institute and Shanghai Renji Hospital, ...
(Date:11/26/2014)... Nov. 25, 2014  At the American Dental Association,s ... this October, KaVo Kerr Group was honored to be ... attendees the opportunity to see and test the Best ... leaders deliver lectures on the latest developments in dental ... the new DEXIS CariVu Caries Detection Device and Kerr ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5CARsgen Completes Series A Financing 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3
... 2011 ViroPharma Incorporated (Nasdaq: VPHM ) today ... ViroPharma, will present at the Citi 2011 Global Healthcare Conference ... conference is being held at the Hilton New York Hotel ... and chief financial officer, of ViroPharma, will present at the ...
... Feb. 28, 2011 Rock Creek Pharmaceuticals, a wholly ... CIGX ) has been notified by the Roskamp Institute ... review board (IRB) approval to conduct a three-month, multi-site ...  The study (referred to as the "Flint Study"), will ...
Cached Medicine Technology:ViroPharma to Participate in Two March Healthcare Conferences 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 2Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 3Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceutical RCP-006 Compound 4
The KAT-Quick Malaria test was designed for the diagnosis of Malaria, in laboratories, the home and for medical kits when travelling into malaria regions....
The Malaria Combo Test is a rapid test for the qualitative detection of Plasmodium falciparum and / or Plasmodium vivax , Plasmodium ovale and Plasmodium malariae antigen in whole blood. This ...
Ultraview SL 3800...
... the Acuity central station and Welch Allyn ... non-monitored beds into centrally monitored beds. Using ... hardwired monitors and clinical devices, the Acuity ... community hospital to a teaching institution. Operating ...
Medicine Products: